Published in Nat Microbiol on July 11, 2016
Tuft Cells: New Players in Colitis. Trends Mol Med (2016) 0.75
A flow-cytometric method to evaluate eosinophil-mediated uptake of probiotic Lactobacillus reuteri. J Microbiol Methods (2017) 0.75
The emerging metabolic view of Clostridium difficile pathogenesis. Curr Opin Microbiol (2016) 0.75
Whole genome sequences of three Clade 3 Clostridium difficile strains carrying binary toxin genes in China. Sci Rep (2017) 0.75
Role of Eosinophils and Tumor Necrosis Factor Alpha in Interleukin-25-Mediated Protection from Amebic Colitis. MBio (2017) 0.75
High prevalence of toxigenic Clostridium difficile in public space lawns in Western Australia. Sci Rep (2017) 0.75
SNP-ing out the differences: Investigating differences between Clostridium difficile lab strains. Virulence (2016) 0.75
Microbiome-mediated neutrophil recruitment via CXCR2 and protection from amebic colitis. PLoS Pathog (2017) 0.75
Toxin A-negative toxin B-positive ribotype 017 Clostridium difficile is the dominant strain type in patients with diarrhoea attending tuberculosis hospitals in Cape Town, South Africa. Eur J Clin Microbiol Infect Dis (2016) 0.75
Genome characterization of a novel binary toxin-positive strain of Clostridium difficile and comparison with the epidemic 027 and 078 strains. Gut Pathog (2017) 0.75
Burden of Clostridium difficile infection in the United States. N Engl J Med (2015) 8.17
Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol (2009) 7.89
Clostridium difficile infection in Europe: a hospital-based survey. Lancet (2011) 6.25
Effects of Clostridium difficile toxins given intragastrically to animals. Infect Immun (1985) 5.44
The role of toxin A and toxin B in Clostridium difficile infection. Nature (2010) 5.32
A mouse model of Clostridium difficile-associated disease. Gastroenterology (2008) 3.65
Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain. Infect Immun (1988) 3.11
Eosinophils: changing perspectives in health and disease. Nat Rev Immunol (2012) 2.69
Clostridium difficile infection: epidemiology, risk factors and management. Nat Rev Gastroenterol Hepatol (2010) 2.61
Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins. Microbiol Mol Biol Rev (2004) 2.60
Production of a complete binary toxin (actin-specific ADP-ribosyltransferase) by Clostridium difficile CD196. Infect Immun (1997) 2.42
Interleukin-22 regulates the complement system to promote resistance against pathobionts after pathogen-induced intestinal damage. Immunity (2014) 2.37
Clostridium difficile toxin CDT induces formation of microtubule-based protrusions and increases adherence of bacteria. PLoS Pathog (2009) 2.29
Functionally competent eosinophils differentiated ex vivo in high purity from normal mouse bone marrow. J Immunol (2008) 2.22
Importance of toxin A, toxin B, and CDT in virulence of an epidemic Clostridium difficile strain. J Infect Dis (2013) 2.03
Clinical features of Clostridium difficile-associated infections and molecular characterization of strains: results of a retrospective study, 2000-2004. Infect Control Hosp Epidemiol (2007) 1.90
Binary toxin and death after Clostridium difficile infection. Emerg Infect Dis (2011) 1.79
Innate Immune Defenses Mediated by Two ILC Subsets Are Critical for Protection against Acute Clostridium difficile Infection. Cell Host Microbe (2015) 1.66
Granulocyte Macrophage Colony-Stimulating Factor-Activated Eosinophils Promote Interleukin-23 Driven Chronic Colitis. Immunity (2015) 1.66
Comparative analysis of Clostridium difficile clinical isolates belonging to different genetic lineages and time periods. J Med Microbiol (2004) 1.45
Clostridium difficile binary toxin CDT: mechanism, epidemiology, and potential clinical importance. Gut Microbes (2013) 1.41
TLR2 agonist ameliorates established allergic airway inflammation by promoting Th1 response and not via regulatory T cells. J Immunol (2005) 1.41
The role of toxin A and toxin B in Clostridium difficile-associated disease: Past and present perspectives. Gut Microbes (2010) 1.37
Lipolysis-stimulated lipoprotein receptor (LSR) is the host receptor for the binary toxin Clostridium difficile transferase (CDT). Proc Natl Acad Sci U S A (2011) 1.31
Binary toxin production in Clostridium difficile is regulated by CdtR, a LytTR family response regulator. J Bacteriol (2007) 1.29
Analysis of the 'angulin' proteins LSR, ILDR1 and ILDR2--tricellulin recruitment, epithelial barrier function and implication in deafness pathogenesis. J Cell Sci (2012) 1.26
Mechanisms of acute eosinophil mobilization from the bone marrow stimulated by interleukin 5: the role of specific adhesion molecules and phosphatidylinositol 3-kinase. J Exp Med (1998) 1.25
Behavior of eosinophil leukocytes in acute inflammation. II. Eosinophil dynamics during acute inflammation. J Clin Invest (1975) 1.20
Murine model of Clostridium difficile infection with aged gnotobiotic C57BL/6 mice and a BI/NAP1 strain. J Infect Dis (2010) 1.19
Predicting recurrence of C. difficile colitis using bacterial virulence factors: binary toxin is the key. J Gastrointest Surg (2012) 1.13
Clostridium difficile toxin A promotes dendritic cell maturation and chemokine CXCL2 expression through p38, IKK, and the NF-kappaB signaling pathway. J Mol Med (Berl) (2008) 1.12
Allergen-induced fluctuation in CC chemokine receptor 3 expression on bone marrow CD34+ cells from asthmatic subjects: significance for mobilization of haemopoietic progenitor cells in allergic inflammation. Immunology (2003) 1.06
Experimental observations on the eosinopenia induced by acute infection. Br J Exp Pathol (1971) 1.06
Role of interleukin 23 signaling in Clostridium difficile colitis. J Infect Dis (2013) 1.05
Eosinophil progenitors in allergy and asthma - do they matter? Pharmacol Ther (2008) 1.04
Eosinophil progenitors in airway diseases: clinical implications. Chest (2008) 1.02
Measuring the inflammasome. Methods Mol Biol (2012) 1.01
Spo0A differentially regulates toxin production in evolutionarily diverse strains of Clostridium difficile. PLoS One (2013) 0.99
Haemopoietic processes in allergic disease: eosinophil/basophil development. Clin Exp Allergy (2009) 0.98
Intestinal inflammatory biomarkers and outcome in pediatric Clostridium difficile infections. J Pediatr (2013) 0.98
Clostridium difficile toxin CDT hijacks microtubule organization and reroutes vesicle traffic to increase pathogen adherence. Proc Natl Acad Sci U S A (2014) 0.93
TLR-2 activation induces regulatory T cells and long-term suppression of asthma manifestations in mice. PLoS One (2013) 0.93
TLR2 agonist ameliorates murine experimental allergic conjunctivitis by inducing CD4 positive T-cell apoptosis rather than by affecting the Th1/Th2 balance. Biochem Biophys Res Commun (2005) 0.93
Roles and regulation of gastrointestinal eosinophils in immunity and disease. J Immunol (2014) 0.91
Clostridium and bacillus binary enterotoxins: bad for the bowels, and eukaryotic being. Toxins (Basel) (2014) 0.91
Thymic stromal lymphopoietin and IL-33 modulate migration of hematopoietic progenitor cells in patients with allergic asthma. J Allergy Clin Immunol (2015) 0.91
Eosinophil adoptive transfer system to directly evaluate pulmonary eosinophil trafficking in vivo. Proc Natl Acad Sci U S A (2013) 0.87
Microbiota-Regulated IL-25 Increases Eosinophil Number to Provide Protection during Clostridium difficile Infection. Cell Rep (2016) 0.86
MAPK-activated protein kinase 2 contributes to Clostridium difficile-associated inflammation. Infect Immun (2012) 0.85
Inflammasome activation contributes to interleukin-23 production in response to Clostridium difficile. MBio (2015) 0.83
Selection of nanobodies that block the enzymatic and cytotoxic activities of the binary Clostridium difficile toxin CDT. Sci Rep (2015) 0.80
Interaction of the Clostridium difficile Binary Toxin CDT and Its Host Cell Receptor, Lipolysis-stimulated Lipoprotein Receptor (LSR). J Biol Chem (2015) 0.76